 D89 |
 |
Other disorders involving the immune mechanism, not elsewhere classified  |
| |
| Excludes1 |
hyperglobulinemia NOS (R77.1)
monoclonal gammopathy (of undetermined significance) (D47.2)
|
| Excludes2 |
transplant failure and rejection (T86.-)
|
|
| |
 D89.0 |
|
Polyclonal hypergammaglobulinemia |
| |
| Benign hypergammaglobulinemic purpura | | Polyclonal gammopathy NOS |
|
|
| |
| D89.1 |
|
Cryoglobulinemia |
| |
| Cryoglobulinemic purpura | | Cryoglobulinemic vasculitis | | Essential cryoglobulinemia | | Idiopathic cryoglobulinemia | | Mixed cryoglobulinemia | | Primary cryoglobulinemia | | Secondary cryoglobulinemia |
|
|
| |
| D89.2 |
|
Hypergammaglobulinemia, unspecified |
|
| |
| D89.3 |
|
Immune reconstitution syndrome |
| |
| Immune reconstitution inflammatory syndrome [IRIS] |
| UseAdditionalCode |
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
|
|
|
| |
| D89.4 |
|
Mast cell activation syndrome and related disorders |
| |
| Excludes1 |
aggressive systemic mastocytosis (C96.21)
congenital cutaneous mastocytosis (Q82.2)
(non-congenital) cutaneous mastocytosis (D47.01)
(indolent) systemic mastocytosis (D47.02)
malignant mast cell neoplasm (C96.2-)
malignant mastocytoma (C96.29)
mast cell leukemia (C94.3-)
mast cell sarcoma (C96.22)
mastocytoma NOS (D47.09)
other mast cell neoplasms of uncertain behavior (D47.09)
systemic mastocytosis associated with a clonal hematologic non-mast cell lineage disease (SM-AHNMD) (D47.02)
|
|
| |
| D89.40 |
|
Mast cell activation, unspecified |
| |
| Mast cell activation disorder, unspecified | | Mast cell activation syndrome, NOS |
|
| | |
| D89.41 |
|
Monoclonal mast cell activation syndrome |
| | |
| D89.42 |
|
Idiopathic mast cell activation syndrome |
| | |
| D89.43 |
|
Secondary mast cell activation |
| |
| Secondary mast cell activation syndrome |
| CodeAlso |
underlying etiology, if known
|
|
| | |
| D89.44 |
|
Hereditary alpha tryptasemia |
| |
| UseAdditionalCode |
code, if applicable, for:
allergy status, other than to drugs and biological substances (Z91.0-)
personal history of anaphylaxis (Z87.892)
|
|
| | |
| D89.49 |
|
Other mast cell activation disorder |
| |
| Other mast cell activation syndrome |
|
| |
| |
| D89.8 |
|
Other specified disorders involving the immune mechanism, not elsewhere classified |
| |
| D89.81 |
|
Graft-versus-host disease |
| |
| CodeFirst |
underlying cause, such as:
complications of transplanted organs and tissue (T86.-)
complications of blood transfusion (T80.89)
|
| UseAdditionalCode |
code to identify associated manifestations, such as:
desquamative dermatitis (L30.8)
diarrhea (R19.7)
elevated bilirubin (R17)
hair loss (L65.9)
|
|
| |
| D89.810 |
|
Acute graft-versus-host disease |
| |
|
| | |
| D89.811 |
|
Chronic graft-versus-host disease |
| |
|
| | |
| D89.812 |
|
Acute on chronic graft-versus-host disease |
| |
|
| | |
| D89.813 |
|
Graft-versus-host disease, unspecified |
| |
|
| | | |
| D89.82 |
|
Autoimmune lymphoproliferative syndrome [ALPS] |
| | |
| D89.83 |
|
Cytokine release syndrome |
| |
| CodeFirst |
underlying cause, such as:
complications following infusion, transfusion and therapeutic injection (T80.89-)
complications of transplanted organs and tissue (T86.-)
|
| UseAdditionalCode |
code to identify associated manifestations
|
|
| |
| D89.831 |
|
Cytokine release syndrome, grade 1 |
| | |
| D89.832 |
|
Cytokine release syndrome, grade 2 |
| | |
| D89.833 |
|
Cytokine release syndrome, grade 3 |
| | |
| D89.834 |
|
Cytokine release syndrome, grade 4 |
| | |
| D89.835 |
|
Cytokine release syndrome, grade 5 |
| | |
| D89.839 |
|
Cytokine release syndrome, grade unspecified |
| | | |
| D89.84 |
|
IgG4-related disease |
| |
| Immunoglobulin G4-related disease |
|
| | |
| D89.89 |
|
Other specified disorders involving the immune mechanism, not elsewhere classified |
| |
| Excludes1 |
human immunodeficiency virus disease (B20)
|
|
| |
| |
| D89.9 |
|
Disorder involving the immune mechanism, unspecified |
| |
|
|